Search

everythinglearnresearchcommunity

for

Search:↓

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

The vellus index is a simple, quick, and reliable method to assess and monitor hair growth, especially in hirsutism.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

Fractional CO2 laser therapy is more effective and safer than corticosteroid injections for treating alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Scientists found a new method using 3D cell cultures to grow human hair which may improve hair restoration treatments.

Measuring 24-OHase induction helps identify defects in vitamin D processing and predict treatment response.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.